TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,300 JPY | -1.15% |
|
-.--% | +8.18% |
| 06-25 | US CDC alerts healthcare providers of increase in dengue cases | RE |
| 06-25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 815B | ||||||
| 641B | ||||||
| 352B | - | - | - | - | ||
| 314B | ||||||
| 303B |
